financetom
Business
financetom
/
Business
/
General Motors Insider Sold Shares Worth $1,227,542, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
General Motors Insider Sold Shares Worth $1,227,542, According to a Recent SEC Filing
Apr 1, 2024 2:25 PM

05:11 PM EDT, 04/01/2024 (MT Newswires) -- Gerald Johnson, Executive Vice President, on March 28, 2024, sold 27,122 shares in General Motors ( GM ) for $1,227,542. Following the Form 4 filing with the SEC, Johnson has control over a total of 71,506 shares of the company, with 71,506 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1467858/000146785824000068/xslF345X03/wk-form4_1712005528.xml

Price: 45.32, Change: -0.08, Percent Change: -0.18

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bessent says TikTok ban threat won framework agreement with Chinese
Bessent says TikTok ban threat won framework agreement with Chinese
Sep 15, 2025
MADRID (Reuters) -U.S. Treasury Secretary Scott Bessent said the threat of a TikTok shutdown led Chinese negotiators to abandon demands for tariff concessions in return for the social media app divestment and allowed reaching a framework agreement in talks in Madrid on Monday. The commercial terms of the agreement will preserve U.S. national security interests and the mobile app's Chinese...
Novo Nordisk's Rybelsus Now First Oral GLP-1 RA In Europe With Proven Heart Health Impact
Novo Nordisk's Rybelsus Now First Oral GLP-1 RA In Europe With Proven Heart Health Impact
Sep 15, 2025
On Monday, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) approved an update to Novo Nordisk A/S ( NVO )‘ Rybelsus (oral semaglutide) label to reflect the cardiovascular benefits seen in the SOUL trial. SOUL was a phase 3b trial carried out to evaluate the effect of Rybelsus on cardiovascular outcomes in people with type 2...
Capital One Financial's Credit Card Delinquency Rises in August
Capital One Financial's Credit Card Delinquency Rises in August
Sep 15, 2025
01:13 PM EDT, 09/15/2025 (MT Newswires) -- Capital One Financial's ( COF ) 30-day-plus credit card delinquency rate was 3.73% on Aug. 31, up from 3.67% a month earlier, according to a Monday regulatory filing. The company reported average domestic credit card loans of $252.48 billion, up from $251.21 billion, and consumer auto loans of $81.15 billion, up from $80.36...
Here's Novo Nordisk's First Oral Obesity Drug In Europe With Proven Heart Health Impact
Here's Novo Nordisk's First Oral Obesity Drug In Europe With Proven Heart Health Impact
Sep 15, 2025
On Monday, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) approved an update to Novo Nordisk A/S ( NVO )‘ Rybelsus (oral semaglutide) label to reflect the cardiovascular benefits seen in the SOUL trial. SOUL was a phase 3b trial carried out to evaluate the effect of Rybelsus on cardiovascular outcomes in people with type 2...
Copyright 2023-2026 - www.financetom.com All Rights Reserved